US narrows use of muscle-wasting therapy after teen deaths

The United States on Friday said it would add its most serious warning label to a gene therapy treatment for a debilitating muscle-wasting disease, and also limit its approved use.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup